TITLE

Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe

AUTHOR(S)
van der Straten, Ariane; Helen Cheng; Minnis, Alexandra M.
PUB. DATE
January 2010
SOURCE
Journal of the International AIDS Society;2010, Vol. 13 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: We examined the use of male condoms and the diaphragm following completion of a clinical trial of the diaphragm's HIV prevention effectiveness. In the trial, called Methods for Improving Reproductive Health in Africa (MIRA), women were randomized to a diaphragm group (diaphragm, gel and condoms) or a condom-only control group. At trial exit, all women were offered the diaphragm and condoms. Methods: Our sample consisted of 801 Zimbabwean MIRA participants who completed one post-trial visit (median lapse: nine months; range two to 20 months). We assessed condom, diaphragm and any barrier method use at last sex act at enrolment, final MIRA and post-trial visits. We used multivariable random effects logistic regression to examine changes in method use between these three time points. Results and discussion: In the condom group, condom use decreased from 86% at the final trial visit to 67% post trial (AOR = 0.20; 95% CI: 0.12 to 0.33). In the diaphragm group, condom use was 61% at the final trial visit, and did not decrease significantly post trial (AOR = 0.77; 95% CI: 0.55 to 1.09), while diaphragm use decreased from 79% to 50% post trial (AOR = 0.18; 95% CI: 0.12 to 0.28). Condom use significantly decreased between the enrolment and post-trial visits in both groups. Use of any barrier method was similar in both groups: it significantly decreased between the final trial and the post-trial visits, but did not change between enrolment and the post-trial visits. Conclusions: High condom use levels achieved during the trial were not sustained post trial in the condom group. Post-trial diaphragm use remained relatively high in the diaphragm group (given its unknown effectiveness), but was very low in the condom group. Introducing "new" methods for HIV prevention may require time and user skills before they get adopted. Our findings underscore the potential benefit of providing a mix of methods to women as it may encourage more protected acts.
ACCESSION #
64933588

 

Related Articles

  • Activists and researchers rally behind AIDS drug for mothers. Check, Erika // Nature;12/23/2004, Vol. 432 Issue 7020, p935 

    The article reports that scientists and patient advocates this week united to defend an HIV treatment against allegations that a key clinical trial of the drug was flawed. The drug, nevirapine, is used to help prevent mother-to-baby transmission of HIV. But stories published by the Associated...

  • Neuro-ventilatory efficiency during weaning from mechanical ventilation using neurally adjusted ventilatory assist. RozĂ©, H.; Repusseau, B.; Perrier, V.; Germain, A.; SĂ©ramondi, R.; Dewitte, A.; Fleureau, C.; Ouattara, A. // BJA: The British Journal of Anaesthesia;Dec2013, Vol. 111 Issue 6, p955 

    Background Neuro-ventilatory efficiency (NVE), defined as the tidal volume to electrical diaphragm-activity ratio (VT/EAdi) at the beginning and end of the weaning process after acute hypoxaemic respiratory failure, may provide valuable information about patient recovery. Methods This...

  • An increase in peak excess pressure accounts for the rise in systolic blood pressure along the aorta. Narayan, O.; Davies, J.; Hughes, A.; Parker, K.; Hope, S.; Meredith, I.; Cameron, J. // Heart, Lung & Circulation;2015 Supplement 3, Vol. 24, pS122 

    No abstract available.

  • CE/CME questions.  // IRB Advisor;Jun2007, Vol. 7 Issue 6, p72 

    A quiz concerning medical research and clinical trials is presented.

  • Strengthening Protection for Trial Subjects.  // BioWorld Today;7/28/2011, Vol. 22 Issue 145, p5 

    The article reports on the plans to revise the Common Rule, a regulation that protects subjects involve in U.S. clinical trials and other human research, in order to address ambiguities and current needs in research as of July 28, 2011.

  • CME Questions.  // OB/GYN Clinical Alert;May2009, Vol. 26 Issue 1, p8 

    A quiz on medical topics is presented.

  • CNE/CME questions.  // Clinical Trials Administrator;Apr2009, Vol. 7 Issue 4, p48 

    A quiz about clinical trials is presented.

  • CNE/CME questions.  // Clinical Trials Administrator;Jan2009, Vol. 7 Issue 1, p12 

    A quiz about clinical trials is presented.

  • CNE/CME questions.  // Clinical Trials Administrator;Aug2009, Vol. 7 Issue 8, p96 

    A quiz about clinical trials is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics